A strong association is observed between circulating aCL IgG antibodies and non-thrombotic cardiac manifestations, including CAD, aortic/mitral/tricuspid regurgitation, mitral valve prolapse, and cardiomyopathy [76]. Here, ACLY is linked to cardiomyopathy.